Mineralys Therapeutics, Inc. (MLYS) Tops Q1 EPS by 29c

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q1 EPS of ($0.79), $0.29 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.

You May Also Be Interested In

• AI and memory not a classic bubble, but future returns uncertain - strategist
• DOE gauged support for voluntarily cutting diesel exports - Reuters
• Roblox (RBLX) call put ratio 1 call to 1.4 puts as share price down 1.8%